SENECA CAPITAL INVESTMENTS, L.P. - C B PHARMA ACQUISITION CORP ownership

C B PHARMA ACQUISITION CORP's ticker is CNLMU and the CUSIP is G2029P100. A total of 6 filers reported holding C B PHARMA ACQUISITION CORP in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SENECA CAPITAL INVESTMENTS, L.P. ownership history of C B PHARMA ACQUISITION CORP
ValueSharesWeighting
Q3 2015$1,570,000
-0.6%
150,0000.0%0.56%
+90.5%
Q2 2015$1,579,000
+3.0%
150,0000.0%0.30%
-15.7%
Q1 2015$1,533,000
+1.8%
150,0000.0%0.35%
-15.6%
Q4 2014$1,506,000150,0000.42%
Other shareholders
C B PHARMA ACQUISITION CORP shareholders Q1 2015
NameSharesValueWeighting ↓
Weiss Asset Management LP 268,246$2,691,0001.09%
SENECA CAPITAL INVESTMENTS, L.P. 150,000$1,506,0000.42%
Polar Asset Management Partners Inc. 750,000$7,530,0000.40%
Context Capital Management, LLC 14,900$150,0000.19%
Kassirer Asset Management Corp 20,000$201,0000.18%
Bulldog Investors, LLP 75,000$753,0000.16%
GLAZER CAPITAL, LLC 63,424$637,0000.09%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 350,000$3,511,0000.07%
AQR Capital Management 350,000$3,511,0000.01%
UBS Group AG 421$4,0000.00%
View complete list of C B PHARMA ACQUISITION CORP shareholders